Drug:
Reaction: ALOPECIA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26538376 |
US |
57 | 2 |
Dehydration, Decreased appetite, Nausea, Vomiting, Constipation, Abdominal pain upper, Diarrhoea, Malnutrition, Alopecia, Dyspepsia, Off label use, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, EPINEPHRINE, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, DARIDOREXANT, DULOXETINE HYDROCHLORIDE, DULOXETINE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ESZOPICLONE, OLANZAPINE, CARIPRAZINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CARISOPRODOL, TIZANIDINE, TIZANIDINE, |
||||
| 102 | 26538489 |
US |
2 | |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 103 | 26538960 |
US |
2 | |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 104 | 26539228 |
US |
||
Alopecia, Product use in unapproved indication, |
||||
DROSPIRENONE, |
||||
| 105 | 26539581 |
US |
||
Alopecia, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 106 | 26539884 |
US |
57 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 107 | 26540823 |
US |
52 | 2 |
Alopecia, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 108 | 26540956 |
US |
6 | 1 |
Alopecia, |
||||
DUPILUMAB, |
||||
| 109 | 26541268 |
US |
||
Alopecia, |
||||
KETOCONAZOLE, |
||||
| 110 | 26531334 |
US |
63 | 2 |
Alopecia, Haemorrhage, Application site reaction, Dyspnoea, Drug ineffective, Depression, Erythema, Headache, Dyspnoea exertional, Hepatic enzyme increased, Inappropriate schedule of product administration, Incorrect dose administered, Insomnia, Intervertebral disc protrusion, Malaise, Muscular weakness, Pain, Paraesthesia, Primary biliary cholangitis, Product dose omission issue, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Wrong technique in product usage process, Tachycardia, |
||||
OMALIZUMAB, |
||||
| 111 | 26531755 |
US |
2 | |
Alopecia, Contusion, |
||||
RAVULIZUMAB, |
||||
| 112 | 26531829 |
US |
67 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 113 | 26531914 |
US |
71 | 2 |
Abdominal pain upper, Alopecia, Nausea, |
||||
TIRZEPATIDE, |
||||
| 114 | 26531920 |
CN |
70 | 1 |
Alopecia, Hypoaesthesia, Underdose, Off label use, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 115 | 26531940 |
US |
||
Withdrawal syndrome, Headache, Dizziness, Paraesthesia, Incorrect dose administered, Palpitations, Tinnitus, Amnesia, Alopecia, Somnolence, Hypertension, Fatigue, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 116 | 26532088 |
US |
57 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 117 | 26532195 |
US |
61 | 2 |
Eczema asteatotic, Inappropriate schedule of product administration, Alopecia, Drug ineffective, Fatigue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 118 | 26532196 |
US |
2 | |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 119 | 26532741 |
US |
62 | 2 |
Fatigue, Asthenia, Somnolence, Hallucination, Chest pain, Dyspnoea, Dry mouth, Stomatitis, Pruritus, Dysphagia, Decreased appetite, Hot flush, Oedema peripheral, Arthralgia, Dry skin, Alopecia, Dizziness, Headache, Hypoaesthesia, Paraesthesia, Depression, Off label use, |
||||
FEDRATINIB HYDROCHLORIDE, ACYCLOVIR, ALLOPURINOL, DARBEPOETIN ALFA, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, COLCHICINE, DONEPEZIL HYDROCHLORIDE, |
||||
| 120 | 26532832 |
US |
||
Off label use, Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 121 | 26532848 |
US |
||
Hair texture abnormal, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 122 | 26533004 |
US |
||
Alopecia, Temperature regulation disorder, Wrong technique in product usage process, Headache, Injection site mass, Injection site pain, |
||||
LANREOTIDE ACETATE, |
||||
| 123 | 26533022 |
BR |
50 | |
Metastases to bone, Immune system disorder, Diarrhoea, Constipation, Alopecia, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 124 | 26533231 |
GB |
||
Medication error, Rhabdomyolysis, Alopecia, Lethargy, Pruritus, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 125 | 26533233 |
CA |
43 | 2 |
Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Depression, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Fatigue, Ear pain, Epilepsy, Exostosis, Facet joint syndrome, Feeling hot, Folliculitis, Fibromyalgia, Frequent bowel movements, Gait disturbance, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injection site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Laryngitis, Lip dry, Liver function test increased, Live birth, Liver disorder, Normal newborn, Maternal exposure during pregnancy, Incorrect route of product administration, Drug ineffective, Intentional product use issue, Intentional product misuse, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, APREMILAST, APREMILAST, APREMILAST, ATOMOXETINE, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, MEPOLIZUMAB, BUPRENORPHINE, BUPRENORPHINE, ACETAMINOPHEN AND CODEINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LANSOPRAZOLE, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 126 | 26533263 |
US |
37 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 127 | 26533475 |
GB |
25 | 2 |
Alopecia, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ACYCLOVIR, |
||||
| 128 | 26533950 |
US |
60 | 2 |
Alopecia, |
||||
ANIFROLUMAB-FNIA, |
||||
| 129 | 26534055 |
EU |
27 | 1 |
Alopecia, Psoriasis, |
||||
INFLIXIMAB, AZATHIOPRINE, |
||||
| 130 | 26534248 |
US |
56 | 2 |
Alopecia, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 131 | 26534271 |
CN |
51 | 2 |
Breast cancer recurrent, Metastasis, Metastases to liver, Granulocytopenia, Palmar-plantar erythrodysaesthesia syndrome, Diarrhoea, Nausea, Hepatic steatosis, Alopecia, |
||||
CAPECITABINE, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 132 | 26534388 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 133 | 26534591 |
65 | 2 | |
Carcinoid tumour, Thyroid mass, Pulmonary mass, Alopecia, Weight increased, |
||||
MAVACAMTEN, |
||||
| 134 | 26534629 |
US |
1 | |
Alopecia, Drug ineffective, |
||||
| 135 | 26535147 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 136 | 26535194 |
US |
59 | 2 |
Hypertension, COVID-19, Impaired gastric emptying, Metabolic disorder, Postprandial hypoglycaemia, Illness, Body temperature decreased, Vomiting, Alopecia, Dehydration, Headache, Blood glucose increased, Autoimmune disorder, Antinuclear antibody positive, Psoriasis, Sinusitis, Influenza, Dumping syndrome, Inappropriate schedule of product administration, Therapeutic response decreased, Overdose, Drug ineffective, Product use issue, |
||||
IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, TIRZEPATIDE, DULAGLUTIDE, LIRAGLUTIDE, |
||||
| 137 | 26535255 |
GB |
66 | 2 |
Myalgia, Skin reaction, Alopecia, Diarrhoea, Constipation, Dizziness, Fatigue, Headache, |
||||
FAMOTIDINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PREGABALIN, |
||||
| 138 | 26535517 |
US |
68 | |
Weight decreased, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 139 | 26535574 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 140 | 26535580 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 141 | 26535590 |
US |
1 | |
Muscle atrophy, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 142 | 26535796 |
US |
53 | 2 |
Blindness, Pruritus, Heart rate increased, Nausea, Fatigue, Flatulence, Dehydration, Alopecia, Dizziness, Dyspepsia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 143 | 26538435 |
45 | 2 | |
Hypersensitivity, Influenza, Contraindicated product prescribed, Contraindicated product administered, Drug hypersensitivity, Burning sensation, Blood pressure increased, Fatigue, Dyspnoea, Gait inability, Immunodeficiency, Aphasia, Feeding disorder, Mast cell activation syndrome, Premature menopause, Alopecia, Muscle atrophy, Amnesia, Chronic fatigue syndrome, Fibromyalgia, Guillain-Barre syndrome, |
||||
PREDNISONE, ERGOCALCIFEROL, |
||||
| 144 | 26539184 |
34 | 2 | |
Alopecia, Therapeutic product effect decreased, |
||||
GALCANEZUMAB-GNLM, |
||||
| 145 | 26539186 |
77 | 2 | |
Alopecia, Dizziness, Heart rate irregular, Dizziness, Epistaxis, |
||||
TRIAMTERENE AND HYDROCHLOROTHIAZIDE, ERGOCALCIFEROL, |
||||
| 146 | 26539282 |
29 | 2 | |
Alopecia, Alopecia, |
||||
FREMANEZUMAB-VFRM, |
||||
| 147 | 26526822 |
|||
Alopecia, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CETIRIZINE HCL, CETIRIZINE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE GEL USP, 1%, CLINDAMYCIN PHOSPHATE TOPICAL, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, PIROXICAM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, |
||||
| 148 | 26527181 |
CA |
44 | 2 |
Bursitis, Dizziness, Asthenia, C-reactive protein abnormal, Alopecia, Adverse event, Asthma, Abdominal pain upper, Adverse drug reaction, Blister, Blood cholesterol increased, Diarrhoea, Discomfort, Abdominal discomfort, Arthropathy, Confusional state, Condition aggravated, Abdominal pain, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 149 | 26527439 |
US |
2 | |
Cardiac disorder, Abdominal pain upper, Dry skin, Skin fissures, Nail growth abnormal, Constipation, Weight decreased, Dehydration, Alopecia, Product dose omission issue, |
||||
OSIMERTINIB, |
||||
| 150 | 26527800 |
US |
69 | 2 |
Sneezing, Rhinorrhoea, Alopecia, Nausea, Vomiting, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, ROSUVASTATIN, |
||||
| 151 | 26528075 |
US |
2 | |
Glaucoma, Blood pressure abnormal, Rash macular, Alopecia, Vision blurred, Eye pruritus, Asthma, |
||||
DUPILUMAB, MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), ALBUTEROL SULFATE, ALBUTEROL, VALSARTAN, DORZOLAMIDE, LATANOPROST, LEFLUNOMIDE, PREDNISONE, PANTOPRAZOLE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, |
||||
| 152 | 26528487 |
US |
68 | 2 |
Headache, Off label use, Alopecia, Eye pain, Blindness transient, |
||||
RITUXIMAB, |
||||
| 153 | 26528724 |
CA |
43 | 2 |
Blepharospasm, Abdominal pain upper, Epilepsy, Gastrooesophageal reflux disease, Pain, Paraesthesia, Vomiting, Taste disorder, Drug intolerance, Abdominal discomfort, Anti-cyclic citrullinated peptide antibody positive, Alopecia, Back injury, Arthralgia, Arthropathy, Drug hypersensitivity, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Confusional state, Depression, Diarrhoea, Duodenal ulcer perforation, Dizziness, Fibromyalgia, Dry mouth, Gait inability, Facet joint syndrome, Folliculitis, Pain in extremity, General physical health deterioration, Maternal exposure during pregnancy, Live birth, Subcutaneous drug absorption impaired, Rash vesicular, Fatigue, Pustular psoriasis, Psoriasis, Malaise, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, RITUXIMAB, OXYCODONE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MAGNESIUM, |
||||
| 154 | 26528818 |
US |
73 | 2 |
Depression, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 155 | 26529090 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 156 | 26529238 |
|||
Alopecia, |
||||
RESMETIROM, |
||||
| 157 | 26529281 |
60 | ||
Alopecia, |
||||
RESMETIROM, |
||||
| 158 | 26530091 |
1 | ||
Alopecia, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, |
||||
| 159 | 26530186 |
US |
47 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 160 | 26530235 |
CN |
45 | 2 |
Hypersensitivity, Decreased appetite, Alopecia, Diffuse large B-cell lymphoma recurrent, Metastases to bone, Asthenia, Myelosuppression, Death, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, |
||||
| 161 | 26530310 |
US |
58 | 2 |
Eye irritation, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 162 | 26530337 |
US |
79 | 2 |
Muscle rupture, Hypoacusis, Night sweats, Pruritus, Alopecia, Contusion, Poor quality sleep, Thinking abnormal, Illness, Arthralgia, Headache, Ear pruritus, Hyperhidrosis, Ecchymosis, Fall, Gait disturbance, Heart rate irregular, Malaise, Middle insomnia, Dizziness, Fatigue, Asthenia, |
||||
VENETOCLAX, VENETOCLAX, RITUXIMAB, |
||||
| 163 | 26530391 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 164 | 26530460 |
US |
57 | 2 |
Infection, Pyrexia, Rhinorrhoea, Alopecia, Condition aggravated, Oedema, Pain in extremity, Peripheral swelling, |
||||
LORLATINIB, LORLATINIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RIVAROXABAN, |
||||
| 165 | 26530818 |
US |
||
Drug ineffective, Pain in extremity, Therapeutic product effect incomplete, Crohn^s disease, Alopecia, Pain, |
||||
ADALIMUMAB, ADALIMUMAB-ATTO, |
||||
| 166 | 26531001 |
GB |
66 | 2 |
Myalgia, Alopecia, Dizziness, Fatigue, Constipation, Headache, Diarrhoea, Skin reaction, |
||||
FAMOTIDINE, PREGABALIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 167 | 26533353 |
50 | 2 | |
Alopecia, |
||||
RIVAROXABAN, |
||||
| 168 | 26522667 |
EU |
63 | 1 |
Neuropathy peripheral, Ageusia, Oral discomfort, Onychoclasis, Alopecia, Nail disorder, |
||||
TALQUETAMAB, TALQUETAMAB, |
||||
| 169 | 26522688 |
GB |
68 | 1 |
Alopecia, Nausea, Hyperhidrosis, Constipation, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 170 | 26522837 |
59 | ||
Hypersensitivity, Abdominal pain, Anorectal discomfort, Decreased appetite, Fatigue, Headache, Nausea, Abdominal discomfort, Weight decreased, Alopecia, |
||||
CERTOLIZUMAB PEGOL, VITAMIN E, ASCORBIC ACID, PREDNISONE, MESALAMINE, MAGNESIUM, GABAPENTIN, |
||||
| 171 | 26522966 |
US |
70 | 2 |
Alopecia, Ageusia, Muscle spasms, Skin cancer, Vision blurred, Muscle spasms, |
||||
VISMODEGIB, VISMODEGIB, MAGNESIUM, VITAMIN C, BIOTIN, |
||||
| 172 | 26523287 |
US |
33 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 173 | 26523441 |
CA |
3 | 2 |
Alopecia, Drug eruption, Drug ineffective, Off label use, Rash, Drug effective for unapproved indication, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, TRAMETINIB, |
||||
| 174 | 26523473 |
US |
70 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 175 | 26523798 |
CA |
40 | 2 |
Abdominal discomfort, Alopecia, Confusional state, Decreased appetite, Discomfort, Drug hypersensitivity, Drug ineffective, Drug-induced liver injury, Dry mouth, Epilepsy, Fall, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, Glossodynia, Injection site reaction, Nausea, Onychomadesis, Pemphigus, Pericarditis, Rash, Rheumatic fever, Rheumatoid arthritis, Treatment failure, Urticaria, Wound, Product use in unapproved indication, Off label use, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, ERENUMAB-AOOE, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, CALCIUM CARBONATE, ANTACID, ERGOCALCIFEROL, VITAMIN A, VITAMIN C, ERGOCALCIFEROL, POVIDONE-IODINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, |
||||
| 176 | 26524097 |
US |
||
Weight decreased, Alopecia, Nausea, Constipation, |
||||
TIRZEPATIDE, |
||||
| 177 | 26524101 |
US |
75 | 2 |
Drug intolerance, Alopecia, Malaise, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 178 | 26525208 |
US |
2 | |
Loss of consciousness, Abdominal distension, Alopecia, Parosmia, Headache, Adverse drug reaction, |
||||
VALSARTAN, VALSARTAN ORAL, |
||||
| 179 | 26525734 |
US |
||
Alopecia, |
||||
KETOCONAZOLE, |
||||
| 180 | 26525947 |
|||
Rheumatoid arthritis, Alopecia, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 181 | 26526503 |
US |
||
Alopecia, |
||||
KETOCONAZOLE, |
||||
| 182 | 26526549 |
CA |
44 | 2 |
Alopecia, Blister, Condition aggravated, Confusional state, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Glossodynia, Hand deformity, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 183 | 26526550 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, HYDROCORTISONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, LEFLUNOMIDE, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 184 | 26526583 |
US |
||
Alopecia, Dyspnoea, |
||||
NERANDOMILAST, |
||||
| 185 | 26522167 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 186 | 26522399 |
US |
55 | 2 |
Onychomalacia, Alopecia, |
||||
ABEMACICLIB, |
||||
| 187 | 26522412 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 188 | 26521210 |
US |
2 | |
Limb operation, Ulcer, Inflammation, Alopecia, Injury, Fall, Impaired work ability, |
||||
UPADACITINIB, |
||||
| 189 | 26521312 |
US |
63 | 2 |
Pain, Constipation, Alopecia, Fatigue, |
||||
ABEMACICLIB, |
||||
| 190 | 26521314 |
US |
75 | 2 |
Pain, Onychoclasis, Diarrhoea, Alopecia, Nausea, |
||||
ABEMACICLIB, |
||||
| 191 | 26521382 |
US |
48 | 2 |
Alopecia, Injection site extravasation, Eczema, Skin lesion, Skin exfoliation, Pruritus, Skin hypopigmentation, Dry skin, Skin hypertrophy, Dermatitis atopic, Rash pruritic, Skin discolouration, Rash, Injection site vesicles, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 192 | 26521475 |
US |
61 | 2 |
Abdominoplasty, Wound dehiscence, Alopecia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 193 | 26521827 |
US |
64 | 2 |
Alopecia, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 194 | 26516953 |
|||
Myalgia, Headache, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 195 | 26517001 |
CA |
44 | 2 |
Rash, Pruritus, Pyrexia, Drug hypersensitivity, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Blister, Decreased appetite, Discomfort, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, VITAMIN C, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, SECUKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, |
||||
| 196 | 26517055 |
CN |
51 | 1 |
Drug intolerance, Fatigue, Myelosuppression, Alopecia, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 197 | 26517100 |
US |
62 | 2 |
Alopecia, Fatigue, Ageusia, Stomatitis, Nasal ulcer, Malaise, |
||||
PERTUZUMAB, TRASTUZUMAB, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, |
||||
| 198 | 26517122 |
US |
53 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 199 | 26517152 |
US |
44 | 2 |
Sleep deficit, Heart rate increased, Dyspnoea, Migraine, Alopecia, Fatigue, Nausea, |
||||
TIRZEPATIDE, |
||||
| 200 | 26517431 |
US |
71 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
